Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Hoy

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 6, 2023
Drug Target Elucidation Through Isolation and Analysis of Drug-Resistant Mutants in Cryptococcus neoformansMichael J Hoy, Joseph Heitman
Current Biology : CB|October 6, 2020
Fungal pathogensSheng Sun, Michael J Hoy, Joseph Heitman
Aging|July 6, 2015
High-glucose diets have sex-specific effects on aging in C. elegans: toxic to hermaphrodites but beneficial to malesMarjorie R Liggett, Michael J Hoy, Michael Mastroianni, et al.
Scientific Reports|May 27, 2018
Evolutionarily Conserved and Divergent Roles of Unfolded Protein Response (UPR) in the Pathogenic Cryptococcus Species ComplexKwang-Woo Jung, Kyung-Tae Lee, Anna F Averette, et al.
Elife|July 8, 2016
Metabolic network rewiring of propionate flux compensates vitamin B12 deficiency in C. elegansEmma Watson, Viridiana Olin-Sandoval, Michael J Hoy, et al.
Mbio|September 22, 2023
Enhanced fungal specificity and <i>in vivo</i> therapeutic efficacy of a C-22-modified FK520 analog against <i>C. neoformans</i>Angela Rivera, Won Young Lim, Eunchong Park, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Enhanced fungal specificity and <i>in vivo</i> therapeutic efficacy of a C-22 modified FK520 analog against <i>C. neoformans</i>Angela Rivera, Won Young Lim, Eunchong Park, et al.
Mbio|May 23, 2022
Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit <i>In Vivo</i> Therapeutic Efficacy against CryptococcusMichael J Hoy, Eunchong Park, Hyunji Lee, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Butyrolactol A is a phospholipid flippase inhibitor that potentiates the bioactivity of caspofungin against resistant fungiXuefei Chen, H Diessel Duan, Michael J Hoy, et al.
Nature Communications|September 21, 2019
Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agentsPraveen R Juvvadi, David Fox, Benjamin G Bobay, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|April 6, 2023
Drug Target Elucidation Through Isolation and Analysis of Drug-Resistant Mutants in Cryptococcus neoformansMichael J Hoy, Joseph Heitman
Current Biology : CB|October 6, 2020
Fungal pathogensSheng Sun, Michael J Hoy, Joseph Heitman
Aging|July 6, 2015
High-glucose diets have sex-specific effects on aging in C. elegans: toxic to hermaphrodites but beneficial to malesMarjorie R Liggett, Michael J Hoy, Michael Mastroianni, et al.
Scientific Reports|May 27, 2018
Evolutionarily Conserved and Divergent Roles of Unfolded Protein Response (UPR) in the Pathogenic Cryptococcus Species ComplexKwang-Woo Jung, Kyung-Tae Lee, Anna F Averette, et al.
Elife|July 8, 2016
Metabolic network rewiring of propionate flux compensates vitamin B12 deficiency in C. elegansEmma Watson, Viridiana Olin-Sandoval, Michael J Hoy, et al.
Mbio|September 22, 2023
Enhanced fungal specificity and <i>in vivo</i> therapeutic efficacy of a C-22-modified FK520 analog against <i>C. neoformans</i>Angela Rivera, Won Young Lim, Eunchong Park, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
Enhanced fungal specificity and <i>in vivo</i> therapeutic efficacy of a C-22 modified FK520 analog against <i>C. neoformans</i>Angela Rivera, Won Young Lim, Eunchong Park, et al.
Mbio|May 23, 2022
Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit <i>In Vivo</i> Therapeutic Efficacy against CryptococcusMichael J Hoy, Eunchong Park, Hyunji Lee, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2025
Butyrolactol A is a phospholipid flippase inhibitor that potentiates the bioactivity of caspofungin against resistant fungiXuefei Chen, H Diessel Duan, Michael J Hoy, et al.
Nature Communications|September 21, 2019
Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agentsPraveen R Juvvadi, David Fox, Benjamin G Bobay, et al.
Pageof 2